© Whole Foods magazine
Curing Heart Disease With Dietary Supplements: Part 1: Cochran Medical Foundation and Clinical Results.
By Richard A. Passwater, Ph.D.
There's no doubt about it. Many of us have known for a long time that natural compounds cure many diseases as well as prevent them. However, our evidence has only been considered "anecdotal." Now, at last, clinical researchers are taking us into the new era of clinical trials with natural compounds in time for the new millennium. Last month, we discussed with Drs. Marvin Bierenbaum and Tom Watkins of the Jordan Heart Foundation how at least one form of atherosclerosis is reversed by antioxidants within a few months. This month we will look at dramatic clinical results from the Cochran Foundation for Medical Research (CFMR), a non-profit organization located in Cedar Pines, CA.
These clinical findings demonstrate that many forms of heart disease may be cured quickly with the appropriate levels of natural compounds available in health food stores. No drugs, exercises or meditation are used in the Cochran Regimen, and yet it has been shown to restore heart and cardiovascular health to patients who previously were thought to be within days to weeks of death.
And there is more good news: preliminary results from clinical trials with Parkinson's disease and autoimmune disease are also very encouraging.
I have been closely monitoring the progress of the clinical trials with the Cochran Regimen since late March or early April of 1997. These results are being published here for the first time anywhere. I have discussed them with several physicians and biochemists for peer review-even taking them to the American Academy for Anti-Aging Medicine Conference in December. There, they were inspected by more than 20 holistic physicians and scientists. Every health professional who has seen these results uses basically the same three words to describe them-"remarkable," "fantastic" and "unbelievable." All have said that these results are the most astounding that they have ever seen using any protocol. Nothing like this has ever been achieved before.
Because the results have been described as "unbelievable," with the meaning being that such results are completely unexpected, we have taken the extraordinary steps of not only fully documenting every detail, but of videotaping the physicians and patients describing the "before" and "after" conditions. Heart patients, who were just days from death, can be seen jumping around. Most look years younger than their chronological ages would suggest. One patient, number 8, an 86-year-old man, looks 10-15 years younger. The documentation of the clinical trials exceeds the requirements for most scientific studies, or even the scrutiny of television's 60 Minutes. However, because the numbers of patients studied so far is too small for scientific conclusions to be drawn, the clinical trials have to be described as "preliminary."
In this opening installment of what will be a two-part series, we chat with Tim Cochran, therapeutic biochemist and founder of the Cochran Foundation for Medical Research, as we examine the heretofore unpublished results from the CFMR's first "open" trial of 23 consecutive seriously-ill heart patients. This open trial enrolled 23 consecutive patients requesting treatment by the Cochran Regimen. Ethics prevented the use of placebos (inert pills that look like the pills being studied), as this practice would surely have resulted in the deaths of these seriously-ill patients.
In the first six months of this clinical trial, the patients improved from an average New York Heart Association level of 3.1 to an average of 1.3 accompanied by amazing improvements in cardiovascular function. On average, their blood pressures dropped from 153.7/113 to 101.5/69.6, and their pulse rates dropped from 104 to 76. Concomitant with these amazing improvements in cardiovascular function, their blood chemistries improved dramatically. On average, their total blood cholesterol levels dropped 39.6 mg/dl, their LDL-cholesterol (the "bad" cholesterol) levels dropped 48.3 mg/dl, their HDL cholesterol (the "good" cholesterol) increased by 14.5 mg/dl, their HDL/LDL ratios improved by 216%, and their triglycerides dropped 29.3 mg/dl. Prior to beginning the Cochran Regimen, medications could not bring about significant improvements. In fact, according to the physicians who have reviewed these preliminary results, no combinations of medicines to present have ever brought about such dramatic improvements.
It may be argued that since these trials are "preliminary," it is premature to present them to the public. It can, however, also be postulated that many lives might be saved without risk if this information could be put to practical use during the years that it will take to present definitive evidence. Since I have experienced excellent results with my Supernutrition Program during the past 30 years, I am confident that the improved Cochran Regimen will continue to produce superior results. Time will be the judge, but for the seriously ill, time is a luxury. So let's get on with the details.
Passwater: Why are you interested in medical research?
Cochran: It started when I was taking biology and chemistry in college. I remember that in my freshman year, I often debated about diseases and aging with my microbiology professors. I would look at aging and tissue degeneration primarily as diseases, or at least as conditions Which allow the physiology medium to change, thus allowing disease to have access to destroy the body. My theory was that if we could manipulate body chemistry, we should be able toy restore tile body back to a stale iii which it was previously.
If we could biochemically manipulate the body chemistry to replicate what it was when you were in your prime, your cells would once again give out the biochemical signals and instructions that mandated that each time a cell split, instead of deteriorating, it would stabilize or be restored to a healthier, more efficient cellular function. This requires more than just restoring blood levels of nutrients and chemical messengers such as hormones to their youthful levels. Cells must first be biochemically commanded to return to their optimal function.
I always have believed strongly that all diseases are just manifestations of abnormalities of molecular processes, of biochemical interfaces and the reactions, that do or do not take place in response to these interfaces.
Needless to say, back in 1974, my professors thought I was eccentric for coming up with this concept, but I have been developing and refining it ever since. In 1975, your book, Supernutrition: Megavitamin Revolution, described your research and offered me great encouragement. Your research and writings have been very instrumental in my research. It seems as if everywhere I turned in the nutritional part of my research, you had already done some research in that area. The same can be said of Dr. Bill Regelson's research and writings on hormones. You two have been my research gurus through my early research years.
Passwater: Thank you. Usually I strike such comments from these interviews, as they sound too self-serving. But if our readers will forgive me, I will leave your remarks in as they will help the reader understand how the Cochran Regimen differs from what has gone be fore. You have synergistically built o> the research of both Dr. Regelson and myself.
Let's go back to what it was about manipulating cellular chemistry and preventing or curing age-related diseases that interested you?
Cochran: By controlling cellular communication we would be able to manipulate the way the body was aging. When you manipulate and control that, then you actually can extend a person's life. By restoring the proper capability and function of the cell, then the entire cellular system, mitochondria (energy production) to DNA and mRNA and their templates start to regain earlier biological cycle capacity. That's what we have been doing in our medical research.
Passwater: What I'm trying to understand is if this was of special interest to you for a very personal reason as often is the case-or were you looking at this for "humanity?"
Cochran: Both. I had my own age related problems-tumors and high blood pressure, and a family history of cardiovascular disease and cancers. These are the genes which I'm carrying. At 19 years of age, I had tumors in my chest and hypertension (150/110 when not on medication). I had the tumors removed surgically. Then at 38 years of age, tumors appeared at the base of my head and upper back area. They began growing faster when I was 39 years old. I was in danger of losing the use of my left arm regardless of whether I had the tumors removed or not. If I didn't have them removed, their size and position between the muscle tissue over my left shoulder blade would eventually make the muscle dysfunctional. On the other hand, having the tumors removed surgically would have removed even more back muscle tissue. On the advice of my physicians, it was decided that surgery would be the better choice, but before the surgery was scheduled, I began taking what I now call the Cochran Regimen. The tumors totally disappeared in three and one-half weeks.
When I showed this to my physicians, they were shocked. They said it was unbelievable and told my wife that it was a miracle. My blood pressure dropped into the 110/70 to 120/80 range, and I was able to discontinue my hypertension medication. I also lost 35 pounds, dropping from 246 to 221 pounds without a conscious effort to diet. My pulse now ranges from 60 to 72 beats per minute.
So it wasn't a "humanity" thing. It was just working on a major disease with one person at a time until it became clear that the majority of people will need this help some time in the latter part of their life cycles.
This is wiry I founded lire Cochran Foundation of Medical Research (CFMR). We now have 12 physicians on staff. We can assist a patient's personal physician without actually seeing the patient here in California. In the case of cardiovascular disease, all we need to know is a patient's history, his or her New York Heart Association (NYHA) level, a full blood work-up
showing the blood lipids including low-density lipoprotein LDL and high-density lipoprotein (HDL) levels, plus a few other biochemical indicators. The n our physicians consult with me, and I do a complicated mathematical modeling drat incorporates all of the biochemical and biophysical factors from nutrient absorption considerations to membrane transport. The goal is to biologically change the patient's current platform and return it to what it was like when the patient was between 18 and 25 years old.
Through this process, each cell is given the resources and the biochemical signs and instructions it requires to start up the hill, so to speak, for tissue regeneration. What people often overlook is that the genetic blueprints that made each of them "them" is still there. The cells still obey the same laws of chemistry and physics that they did when the person was 18 years old. It is just that the cellular molecular language and command structure has been out of operation for the past 30 or 40 years in age-related disease. I then determine which nutrients and hormones are needed and how much of each. Since each has an effect on the other, the inter-relationships are quite complex. The goal is to nourish each cell with what it needs and to give each cell the biochemical signals and instructions it needs to restore full function.
Passwater: Could you tell us how the Cochran Foundation of Medical Research-CFMR-contributes to your work?
Cochran: CFMR is a non-profit medical foundation specializing in biochemical treatments for cardiovascular and autoimmune conditions, as well as Parkinson's disease, Huntington's disease and muscular dystrophy. We believe that an awful lot of this damage is caused by gene /chromosome, DNA and RNA deterioration and mutation caused by a host of cellular insult damages including oxidation of cellular components and toxins.
As we age, this damage increases and the biochemical communications start to decline. The decline is slow at first, but then increases at an aver compounding rate. We undertake to stop the deterioration and give biochemical stimulants that will help cause regeneration. These include hormones, amino acids and enzyme,,, which are chemical messengers and instructors that can communicate with cells. hi addition, we nourish the cells with the vitamins, minerals, essential fatty acids and still more amino acids that they need to rebuild and do their job.
Passwater: Where and when was the CFMR formed?
Cochran: Several physicians, my wife and I began the founding discussion in Cedar Pines Park, CA in July, 1996.
Passwater: Why did you feel it was necessary to form a foundation?
Cochran: A formal structure was needed to process information required for the monitoring of patients, for running medical trials properly, for preparing and getting the trial data, and for preparing the data for medical reports and articles. A foundation could set the goals to only do medical research, mainly in age-related diseases. There needed to be a structure that would be able to accept and handle incoming grants, donations, capital, funding, etc. That money is then protected for the sole use of doing medical research. A foundation would bypass a lot of the headaches that regular companies or institutions would have.
Passwater: Basically, you have supported the Cochran Foundation of Medical Research from funds you yourself have provided.
Cochran: Yes. I can remember one professor saying, "If those are your ideas and you have the money to prove it, then that's fine. But you aren't going to get that kind of grant money from somebody else." So I put my money where my thoughts were.
The other thing that always worried me about grant money, and this is based on what I have heard from friends in academia, is the sad manner in which grants often are tied to someone else's protocols and ideas. Unfortunately, these protocols and ideas may not have any merit during the research. Grants strap limitations on researchers. If you lave been doing research with only one nutrient, say vitamin I?, and you think it would be a really good idea to put six different carotene,, in there and see what the effect would be, the grant limitations would preclude it. Your grant money is only for research with Vitamin I?, and that's all you call do.
There are a lot of restrictions with grants. We don't have those kinds of limitations here at CFMR We have the intellectual freedom to be able to pursue whatever leads come up. If we are working with a lupus patient and really think this individual needs a higher dosage of something, or that some other substance should be added to the mix, we can go where our minds lead.
Passwater: Did you work with patients before forming CFMR?
Cochran: Soon after planning CFMR, near the end of 1996, I had the opportunity to test my regimen on our first "pilot" patient who was being treated by three cardiologists at Stanford University. He was in a hospital being run in conjunction with Stanford up in the San Jose area.
Passwater: The cardiologists were willing to go along with your regimen?
Cochran: They were very opposed to it, but they told the patient that if he wanted to do it, he should go ahead and do it. They didn't feel the regimen would have any benefits whatsoever. But by March, 1997 (the patient had started on December 20, 1996), we were seeing startling results.
Passwater: What was the reaction of the cardiologists?
Cochran: They had never seen any results like this before, and they began to gladly work with us.
Passwater: How did you measure his improvement?
Cochran: He was a New York Heart Association (NYHA) level 4, which is near death, and he is now down to a level 1 or 0. Here we had someone in the process of dying, someone who wasn't given much ton longer to live, and lie is doing substantially better [low, almost without detectable disease.
Passwater: What many of us would love to know is how you got 1)8S1 the first barrier in order to try out your program. There are countless numbers of us who have been pleading for years with members of the medical community., asking them to incorporate nutritional components in their treatment protocols. How did you get the orthodox physicians in such a prestigious university to begin using your regimen?
You said that this first patient was a person that cardiologists at Stanford University had been treating for 10 years. He was near death. Essentially, you went in, without medical credentials, or the results from clinical trials, or even a peer-reviewed theoretical publication, and said, "Fellows, give this dying man my regimen of 70 natural compounds." What ever made them acquiesce?
Cochran: Basically it was the patient's call. I told the patient, "Here are some of my reports; this is what I advise you to do." The patient said he was dying anyway. These cardiologists had him for 10 years and they had done their best, but he was still dying. So he decided to give our regimen an opportunity to see if it worked.
The patient's improvement was miraculous. Based on working with this pilot patient, we went to more patients and then to an open trial of 23 patients. I contacted you after having success with several other patients and just as we started the open trials. We are now starting a fairly large closed clinical trial based on the successful results of the open trial.
Passwater: Do you discontinue the patient's medication when you use your regimen of natural compounds?
Cochran: Very soon after starting. Let me use the pilot patient as an example. His, blood pressure was 140 over 95-100 when put on the Cochran Regimen. His blood pressure and pulse promptly lowered and his arteries became more pliable. The natural compounds in my regimen latched on to the cholesterol build-up in his arteries and started removing it from the artery walls. These improvements occur rapidly with my regimen, and the patient can be weaned off medication quickly.
When we saw that his blood pressure had stabilized at 100 over 60 and his pulse was 54, we weaned the patient of his medication. He had been on substantial amounts of hypertension and beta blocker drugs. We wanted to wean the patient from these drugs because they have adverse effects. The drugs themselves can cause serious irregularities and other coronary problems. They can also suppress the immune system and even suppress vital hormone production.
The cardiologists started dropping off the drugs one by one, and the patient continued to improve.
Since then, we have used my regimen with patients on various medications and still have achieved positive results over a period of time and were able, eventually, to get the patients off the medications that they were on previously. You really don't need medication when you are a NYHA level 1 or level 0 and you have a pulse of 65 and a blood pressure of 110 over 60. Drugs just are not needed any more.
Passwater: How did other doctors become involved?
Cochran: The Stanford cardiologists became very convinced and the information spread to other doctors including a long-time associate who formed our foundation in India. At that point, we enrolled four cardiovascular patients in the U.S. and started doing larger, open pilot trials in India; these began on March 1, 1997. We wanted to develop the data necessary to convince other physicians that the Cochran Regimen works. We needed to find a few patients who were in the process of dying and restore their health and vigor.
The doctor pool in India has now seen 40 severely ill patients and they have all gotten better. You have a small percentage where there is a marginal improvements (7%), but the vast majority (93%) have a very substantial improvement, and the longer they stay on the regimen, the better they get.
Passwater: How did you happen to get to India? Is it just by chance that you knew this one doctor who also practiced in India?
Cochran: 1 have known Dr. Pravin Kini for seven years, and I had a working dialogue with him. Some of the cardiologists in India told us that representatives of major institutions had come over and tried to point out the advances made in the U.S. in terms of bypass surgery or angioplasty. What these people overlooked was that a quadruple bypass may cost $100,000 $125,000. It doesn't help the average Indian to learn how these procedures are done; the average Indian doesn't make this much money in an entire lifetime. Also, there are no medical insurance programs in India as we have in the United States to pay for bypass and related surgeries.
Passwater: It was fortuitous that you personally knew a doctor who had ties to practicing cardiologists in India and that the conditions were ripe for those physicians to look at something nutritionally as opposed to spending thousands of dollars a year on medicines and tens of thousands for operations. What did you do in India first?
Cochran: Dr. Kini enlisted physicians in outlying areas who had patients in the process of dying. These doctors knew there was not much they could do for these patients. So, when our doctors would approach them, they mentioned those dying patients and were willing to try the biochemists' regimen on them and to see what would happen.
By the way, I shouldn't give the impression that these doctors were quite that easy. There were a lot of data that had to be exchanged, a lot of information, lots of talks on the phone for hours. They had numerous questions about what 1 was trying to accomplish, what was going to be done and whether it was going to work. Basically, they listened with open minds and became convinced.
Passwater: Alter they were convinced, how did they convince their patients?
Cochran: They explained to the patients that an American biochemist had come up with a regimen that they felt had merit. Since there was nothing else the doctor had to offer the patient, and his life was ending, this nutritional therapy the biochemist offered was worth a try. The doctors gave the patients a choice, and they told the patients that if there were any adverse effects the patients could be pulled off the treatment, with the understanding that whatever those adverse effects were, they would be gone within 48 to 72 hours.
Passwater: What happened next?
Cochran: The physicians supplied me with the clinical and biochemical information needed to determine the dosages for each patient. The more severe the disease and the older the patient, the more nutrient power is needed to reverse the downward spiral. One size does not fit all.
Passwater: How many natural components are in the regimen that you prescribe for them?
Cochran: Seventy. These include hormones, vitamins, minerals, amino acids, essential fatty acids, coenzymes and enzymes. It is not only a factor of the disease and age of the patient; the person's biochemical individuality must also be considered. Everybody's liver isn't synthesizing things at the same rate. Everyone's organs aren't responding to insulin in the same way. When you start having high blood sugars-and many, if not most people with coronary artery disease are just floating into diabetes type II-you have to look at collateral damage which is going on. There are a lot of other things that have to be looked at. If we fix the guy's heart, what good is it if his liver is gone?
Passwater: This is radically different from the concept of one disease, one pill. You have heart disease, here is a beta-blacker for you.
Cochran: Yes, radically different. When we go for liver synthesization we want that liver to start producing and functioning properly. We want that heart to start pumping with more torque and more power than it was previously doing. You are only going to get that by Stimulating mitochondria efficiency inside tile heart muscles.
Passwater: But even though it is radically different, it is probably more attuned with what the body normally does naturally as opposed to the ways in which drugs work.
Cochran: Yes. I am not against drugs; they have their place in medicine, and the average life expectancy wouldn't have gotten to where it is without them. But the thing people have to remember about drugs is this: most of them are made out of components which the body doesn't totally understand or totally accept. So you may have a positive effect in one way, but you often have a negative or derogatory effect on something else. Drug A takes care of one problem, but a side effect develops from taking drug A. So they give the patient drug B, and it covers or masks the effects of drug A. Then drug B causes a problem. Just because you are masking a problem doesn't mean you have made it go away. You still have deterioration going on.
Passwater: This study in India with your first number of patients would the physicians give them only your regimen or a combination of your regimen plus other medications?
Cochran: In cases where patients were on hypertension and/or diabetes medicine or beta blockers, we advised the doctors to start the regimen and, when they started seeing improvement in the patient, to start diminishing the hypertension medicine. As the IV patients improved, the physicians would wean them off their standard medications. It does not take long to be able to wean most patients completely from drugs.
Passwater: How do the patients differentiate what is achieved by the Cochran Regimen as opposed to what is achieved by the medicine?
Cochran: Most of these patients are totally off their medications within four to six weeks. A lot were on no medication whatsoever in India.
Passwater: Are the results obtained with the Cochran Regimen nearly as good as taking medicine, about the same as taking medicine or better than those achieved by taking medicine?
Cochran: They are substantially better than anything out there presently.
Passwater: Let's look at some of your results. Here are the reports from the initial open trial in India. First, let's see how they did overall as judged by standard evaluation criteria originally developed by the NYHA. The NYHA criteria are listed in Table 1, but basically, level 4 represents a patient near death, and level 1 is very mild. What changes occurred in what time-frame?
Cochran: The "open" clinical trial supervised by Dr. Kini consisted of 21 males and two females ranging in age from 45 to 86, with their average age being 64.5 years.
New York Heart Association
Class Functional Classification
1 Patients have cardiac disease but without resulting limitations of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain.
2 Patients have cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitations, dyspnea, or anginal pain.
3 Patients have cardiac disease resulting in marked limitation of physical
activity. They are less comfortable at rest. Less than ordinary physical activity causes fatigue, palpitations, dyspnea, or anginal pain.
4 Patients have cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or of the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.
Courtesy of New York Heart Association.
Table 2 lists the patients' NYHA ratings at the start and after just six months on my regimen. You can see that on the average, they went from 3.1 to 1.3 in just six months. Four patients went from level 4 to level 1, two from 4 to 2, and eight from 3 to 1. Perhaps Figure 1 shows this better graphically.
Passwater: In order to see that degree of improvement, there should be marked improvements in cardiovascular function. Heart efficiency should improve, which can be measured by the pulse, and the performance of the arteries should be improved, as measured by blood pressure. What can you tell us about these measurements?
Cochran: The patients' heart efficiency improved quickly. As their hearts strengthened, they were able to contract with greater force and push blood through the system more efficiently with fewer contractions required. On the average, the pulse rates dropped 28 beats per minute. They decreased from an average of 104 (range 84-140) to an average of 76 (range 60-120). The range of pulse rate decreases was from 6 to 76 beats per minute. Table 3 lists the patients starting and 6-months pulses. The changes are shown graphically in Figure 2.
Passwater: The greater strength of contraction results in greater heart efficiency. How about the efficiency of the delivery system, the arteries?
Cochran: As the arteries grew healthier, they became more flexible and required less pressure to pump even more blood through them. On the average, the patients' blood pressure readings dropped from 153.7/113 mmHg to 101.5/69.6 mmHg. The best improvement in systolic (top number) pressure range of improvement was 78 mmHg, with the average being 52.2 mmHg. The best improvement in diastolic (bottom number) was 60 mmHg, with the average drop being 43.4 mmHg. Table 3 lists the patients' blood pressures readings, and Figures 3 and 4 show the improvement graphically.
Passwater: Several of the nutrients in your regimen are known to increase the mitochondrial energy in the heart which strengthens the heartbeat. Too bad more cardiologists aren't aware of this. Maybe your clinical studies will cause them to look at this phenomenon more seriously. However, the remarkable improvements in blood pressure have surprised all of the holistic physicians to whom I have shown the data.
Cochran: important to understand that these natural compounds have to be administered together in the proper quantities. The cells must receive the proper chemical instructions along with the resources needed to accomplish the results. It is not just one or two compounds working to increase mitochondrial energy, and another one or two compounds working to improve blood pressure, and another one or two compounds working to reduce cholesterol levels-it's 70 specific natural compounds in specific ratios that include hormones, coenzymes, vitamins, minerals and amino acids that synergistically work together to improve all of the cells in the body. It is just that in the case of heart disease, the biggest changes occur in the heart, arteries and blood chemistry. Back in the 1960's, you discovered that antioxidants can work together synergistically to dramatically and unexpectedly reduce free radical damage. I believe that this was such a new concept that you received patents on it in 1970. Well, this concept also involves unexpected synergy.
Passwater: Then let's look at the results of this synergy in terms of blood chemistry. So far, we have learned that the health of the patients has improved and that their heart and artery efficiencies have improved much more than one normally expects from medications. Further, most medications have adverse affects. What can you tell us about the patients' blood chemistry?
Cochran: They have demonstrated significant improve menu in total blood cholesterol, LDL cholesterol, HDL-cholesterol, LDL/HDL ratios and triglycerides.
Table 4 lists the patients total cholesterol values for the eight patients from the first clinic at the start and six months into the Cochran Regimen. On the average, their total blood cholesterol dropped from 233.4 to 193.8 mg/dl .Most cardiologists consider anything below 200 mg/dl to be good. There was an average decrease of 39.6 mg/dl with the decreases ranging from 13 to 60 mg/dl.
The drop in total blood cholesterol was at the expense of the "bad" cholesterol-the LDL-cholesterol- averaged a 48.3 mg/dl drop (174.3-126.0). The LDL cholesterol decreases ranged from 10 to 72 mg/dl.
Unlike with most medications which lower total cholesterol or LDL-cholesterol, the nutrient regimen improved levels of the "good" HDL-cholesterol. The average increase in HDL-cholesterol was 14.5 mg/dl (25.75-40.25), with the range of increases being from 2 to 22 mg/dl. The improvement in HDL/LDL ratio was 216% (0.148-0.319).
Average triglyceride levels fell 29 mg/dl (167.75-138.5), with a range from 12 to 51 mg/dl.
Passwater: Well that's the preliminary clinical evidence. We'll discuss some of the details of the Cochran Regimen and the theory and reasoning behind this approach in Part 2. WF
Patient Total Total LDL LDL HDL HDL
No. Cholesterol Cholesterol Cholesterol Cholesterol Cholesterol Cholesterol
(Start) (6-months) (Start) (6-months) (Start) (6months)
Mg/dl Mg/dl Mg/dl Mg/dl Mg/dl Mg/dl
3 230 180 176 111 18 38
8 260 200 206 134 20 40
13 224 188 162 122 30 38
14 198 171 143 104 26 41
16 254 200 193 127 24 45
19 256 215 188 135 33 55
21 232 196 167 126 32 40
22 213 200 159 149 23 25
Avg. 233.4 193.8 174.3 126.0 25.8 40.3
© 1998 Whole Foods Magazine and Richard A. Passwater, Ph.D.
This article is copyrighted and may not be re-produced in any form (including electronic) without the written permission of the copyright owners.